![John Varian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Varian
Président chez
SELLAS LIFE SCIENCES GROUP, INC.
Fortune : 213 199 $ au 31/05/2026
Profil
John W.
Varian is Chairman at SELLAS Life Sciences Group, Inc. since 2024 and has been with the company since 2017.
He is Director at Sellas Life Sciences Group Ltd. since 2017.
He serves as Director at AmMax Bio, Inc. and is a Founding Member of The Bay Area.
Formerly, Mr. Varian was Chief Executive Officer & Director at XOMA Royalty Corp.
from 2011 to 2016.
He was Director at Zyla Life Sciences LLC from 2018 to 2019 and Independent Director at Versartis, Inc. from 2014 to 2018.
He served as Independent Director at Acorda Therapeutics, Inc. from 2022 to 2024.
He was Chief Financial Officer at Neurex Corp.
from 1997 to 1998 and Chief Financial Officer & Vice President-Finance at Anergen, Inc. from 1991 to 1997.
He held the position of Chief Financial Officer at Serono Genetics Institute SA and Gen Set SpA from 2000 to 2002.
He was Senior Vice President-Finance & Administration at Elan Pharmaceuticals LLC from 1998 to 2000.
He was Chief Operating & Financial Officer at ARYx Therapeutics, Inc. from 2003 to 2011 and at Nventa Biopharmaceuticals Corp.
He was Audit Principal & Senior Manager at Ernst & Young LLP (Missouri) from 1987 to 1991.
He was Chairman of The Association of Bioscience Financial Officers.
Mr. Varian completed undergraduate studies at Western Michigan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 22 900 ( 0,01 % ) | 213 199 $ | 31/05/2026 |
Postes actifs de John Varian
| Sociétés | Poste | Début |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Président | 01/06/2024 |
AmMax Bio, Inc.
 AmMax Bio, Inc. BiotechnologyHealth Technology Operates a clinical stage biotech company | Directeur/Membre du Conseil | - |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 29/12/2017 |
The Bay Area
 The Bay Area BiotechnologyHealth Technology Provides biomedical advocacy services | Corporate Officer/Principal | - |
Anciens postes connus de John Varian
| Sociétés | Poste | Fin |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/08/2024 |
| ZYLA LIFE SCIENCES | Directeur/Membre du Conseil | 01/02/2019 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Directeur/Membre du Conseil | 12/10/2018 |
| XOMA ROYALTY CORPORATION | Directeur Général | 21/12/2016 |
| ARYX THERAPEUTICS, INC. | Directeur Financier/CFO | 01/08/2011 |
Formation de John Varian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Neurex Corp.
 Neurex Corp. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Anergen, Inc.
 Anergen, Inc. BiotechnologyHealth Technology Develops propriety therapeutics designed to interrupt the antigen process | Health Technology |
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company specializing in synthetic DNA and genetic analysis | Commercial Services |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
Gen Set SpA
 Gen Set SpA Electrical ProductsProducer Manufacturing Manufactures portable generators | Producer Manufacturing |
ARYx Therapeutics, Inc.
 ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Western Michigan University
 Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
The Bay Area
The Bay Area BiotechnologyHealth Technology Provides biomedical advocacy services | Health Technology |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SELLAS Life Sciences Group, Inc. /Old/
 SELLAS Life Sciences Group, Inc. /Old/ BiotechnologyHealth Technology Operates clinical-stage biopharmaceutical company | Health Technology |
SELLAS Life Sciences Group, Inc.
 SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
AmMax Bio, Inc.
AmMax Bio, Inc. BiotechnologyHealth Technology Operates a clinical stage biotech company | Health Technology |
